Cargando…
The Process Chain for Peptidomic Biomarker Discovery
Over the last few years the interest in diagnostic markers for specific diseases has increased continuously. It is expected that they not only improve a patient's medical treatment but also contribute to accelerating the process of drug development. This demand for new biomarkers is caused by a...
Autores principales: | Schrader, Michael, Selle, Hartmut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850862/ https://www.ncbi.nlm.nih.gov/pubmed/16410650 http://dx.doi.org/10.1155/2006/174849 |
Ejemplares similares
-
Identification of potential antigenic peptides of Brucella through proteome and peptidome
por: Pei, Meijuan, et al.
Publicado: (2022) -
Peptidomics screening for the discovery of uterotonic plant peptides
por: Koehbach, Johannes, et al.
Publicado: (2012) -
Comparison of the amniotic fluid and fetal urine peptidome for biomarker discovery in renal developmental disease
por: Fédou, Camille, et al.
Publicado: (2020) -
Urinary Peptidomic Biomarkers in Kidney Diseases
por: Sirolli, Vittorio, et al.
Publicado: (2019) -
Shotgun Proteomics and Biomarker Discovery
por: McDonald, W. Hayes, et al.
Publicado: (2002)